← FDA DRUG APPROVALS

FDA ANDA · ANDA091575

TROSPIUM CHLORIDE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA091575
TYPE
ANDA
ORIGINAL APPROVAL
2010-08-13
LATEST ACTION
2025-04-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

TROSPIUM CHLORIDEPrescription
TROSPIUM CHLORIDE 20MG · TABLET · ORAL

Approval history

2025-04-04Labeling · Supplement 11 · standardAP
2013-12-31Labeling · Supplement 8 · standardAP
2013-07-31Labeling · Supplement 7 · standardAP
2012-11-30Labeling · Supplement 5 · standardAP
2012-05-31Labeling · Supplement 3AP
2011-03-31Labeling · Supplement 1AP
2010-08-13OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →